Debt-to-equity of TREACE MEDICAL CONCEPTS, INC. from 30 Sep 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TREACE MEDICAL CONCEPTS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 31 Dec 2025.
  • TREACE MEDICAL CONCEPTS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 111%, a 14% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TREACE MEDICAL CONCEPTS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 111% +14% +14% 31 Dec 2025
Q3 2025 104% +10% +11% 30 Sep 2025
Q2 2025 100% +13% +15% 30 Jun 2025
Q1 2025 98% +20% +25% 31 Mar 2025
Q4 2024 97% +27% +39% 31 Dec 2024
Q3 2024 94% +16% +21% 30 Sep 2024
Q2 2024 87% -2.4% -2.7% 30 Jun 2024
Q1 2024 78% -27% -26% 31 Mar 2024
Q4 2023 70% -51% -42% 31 Dec 2023
Q3 2023 78% -14% -16% 30 Sep 2023
Q2 2023 89% +22% +33% 30 Jun 2023
Q1 2023 105% +56% +114% 31 Mar 2023
Q4 2022 121% +64% +114% 31 Dec 2022
Q3 2022 92% +13% +16% 30 Sep 2022
Q2 2022 67% 30 Jun 2022
Q1 2022 49% 31 Mar 2022
Q4 2021 57% 31 Dec 2021
Q3 2021 79% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.